viral-immunotherapy
(2)Legend
Company
Executive · Scientist · Operator
Helena Chaye Spent 20 Years Looking for the Right Virus
A virologist went to law school, learned patents were only the beginning, and built a career carrying engineered viruses from the lab toward the clinic. At KaliVir, every detour has become part of the job.
helena-chaye · kalivir-immunotherapeuticsRead →
Health · Enterprise
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics is a clinical-stage biotech developing next-generation oncolytic viral immunotherapies for cancer. Its proprietary Vaccinia Enhanced Template (VET) platform engineers vaccinia viruses that can be delivered intravenously, replicate selectively in tumors, and express therapeutic payloads that reshape the tumor microenvironment. Founded in 2019 and headquartered in Pittsburgh, the company advances an internal lead candidate, VET3-TGI, alongside partnered programs licensed to Astellas Pharma and Roche.
oncolytic-virus · vaccinia-virusRead →